Aptevo Therapeutics Inc. (APVO) Total assets 2016–2023
Aptevo Therapeutics Inc. (APVO) total assets at each fiscal year-end, per SEC filings.
$34.2MFY2023 · since FY2016: $127.8M → $34.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $34.2M | -39.6% |
| FY2022 | $56.6M | +5.7% |
| FY2021 | $53.5M | +0.3% |
| FY2020 | $53.4M | -20.9% |
| FY2019 | $67.5M | -42.3% |
| FY2018 | $117.0M | +27.4% |
| FY2017 | $91.9M | -28.1% |
| FY2016 | $127.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More APVO financial trends
APVO RevenueAPVO Net incomeAPVO Net marginAPVO Gross profitAPVO Gross marginAPVO Operating incomeAPVO Operating marginAPVO Operating cash flowAPVO Free cash flowAPVO Capital expendituresAPVO Return on equityAPVO Stock buybacksAPVO Dividends paidAPVO Total liabilitiesAPVO Shareholders’ equityAPVO overview →